Literature DB >> 20485174

Implications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens.

Charles S Via1.   

Abstract

PURPOSE OF REVIEW: The central role of CD4 T cells in lupus pathogenesis is well recognized; however, the mechanism by which CD4 T cells lose tolerance and promote humoral autoimmunity remains unclear. This review examines mechanisms elucidated in the parent-into-F1 model of lupus and their possible parallels in human lupus pathogenesis. RECENT
FINDINGS: In the parent-into-F1 model, lupus results from the transfer of normal, foreign reactive CD4 T cells targeted to intrinsically normal F1 B cells. Transfer of normal CD8 T cells prevents lupus, whereas transfer of CD8 T cells with killing defects does not but is correctable with additional in-vivo enhancement of CD8 cytotoxic T lymphocyte (CTL) function. The parent-into-F1 model has two major similarities to Epstein-Barr virus infection: CD4 T-cell-driven polyclonal B-cell hyperactivity and a critical dependence on CD8 CTL for elimination of activated B cells. These similarities are discussed in relation to human lupus pathogenesis.
SUMMARY: Work in the parent-into-F1 model supports the idea that lupus may result from defective CD8 T-cell function and that therapeutic enhancement of CD8 effectors with selective targeting to autoreactive B cells may be beneficial. Despite strong evidence linking Epstein-Barr virus infection with human lupus, the exact nature of this link requires further study.

Entities:  

Mesh:

Year:  2010        PMID: 20485174      PMCID: PMC3204365          DOI: 10.1097/BOR.0b013e32833b0174

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  45 in total

Review 1.  The chronic graft-versus-host model of systemic autoimmunity.

Authors:  Robert Eisenberg
Journal:  Curr Dir Autoimmun       Date:  2003

2.  Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.

Authors:  J A James; B R Neas; K L Moser; T Hall; G R Bruner; A L Sestak; J B Harley
Journal:  Arthritis Rheum       Date:  2001-05

3.  Induction of autoantibody production is limited in nonautoimmune mice.

Authors:  Ram Raj Singh; Fanny M Ebling; D Alves Albuquerque; Vijay Saxena; Vipin Kumar; Edward H Giannini; Tony N Marion; Fred D Finkelman; Bevra H Hahn
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

Review 4.  From T to B and back again: positive feedback in systemic autoimmune disease.

Authors:  M J Shlomchik; J E Craft; M J Mamula
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 5.  Advances in lupus stemming from the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Trends Immunol       Date:  2010-03-31       Impact factor: 16.687

6.  Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease.

Authors:  J R Tschetter; E Mozes; G M Shearer
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

Review 7.  An update on genetic studies of systemic lupus erythematosus.

Authors:  Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

8.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

Authors:  Melissa R Arbuckle; Micah T McClain; Mark V Rubertone; R Hal Scofield; Gregory J Dennis; Judith A James; John B Harley
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

9.  Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.

Authors:  Insoo Kang; Timothy Quan; Helena Nolasco; Sung-Hwan Park; Myung Sun Hong; Jill Crouch; Eric G Pamer; John Greg Howe; Joe Craft
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 10.  Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping.

Authors:  W M Prodinger
Journal:  Immunol Res       Date:  1999       Impact factor: 4.505

View more
  4 in total

1.  Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Roman Puliaev; Irina Puliaeva; Charles S Via
Journal:  Clin Immunol       Date:  2018-06-22       Impact factor: 3.969

2.  B cell depletion in murine lupus using cytotoxic T lymphocytes in vivo: Feasibility and benefit.

Authors:  Kateryna Soloviova; Irina Puliaeva; Maksym Puliaiev; Roman Puliaev; Charles S Via
Journal:  Cell Immunol       Date:  2020-05-05       Impact factor: 4.868

Review 3.  Lupus and Epstein-Barr.

Authors:  Judith A James; Julie M Robertson
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

4.  Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Clifton L Dalgard; Brian C Schaefer; Charles S Via
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.